Boothbay Fund Management »

Sage Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $11M 1.4M 7.95
2024-12-31 $7.5M 1.4M 5.43
2024-06-30 $5.1M 474k 10.86
2022-12-31 $443k 12k 38.14
2022-09-30 $1.0M 26k 39.15
2022-06-30 $992k 31k 32.31
2022-03-31 $2.0M 61k 33.11
2021-06-30 $3.3M 58k 56.79
2021-03-31 $795k 11k 74.85
2020-12-31 $663k 7.7k 86.51
2020-09-30 $858k 14k 61.14
2020-06-30 $1.0M 24k 41.60
2020-03-31 $606k 21k 28.70
2019-12-31 $1.6M 23k 72.17
2018-06-30 $357k 2.3k 156.72
2018-03-31 $602k 3.7k 161.18
2017-12-31 $644k 3.9k 164.79